This content is for educational purposes only and is not medical advice
PLA, Polylactic acid
A URRA is a document frequently prepared for HF regulatory submissions to the FDA, evaluating tasks for foreseeable use-related risks and mitigations
Elmonem Lincoln International Institute for Rural Health, University of Lincoln, Lincoln, UK Luchuo Engelbert Bain Department of International Cyber Education, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia Ryenchindorj Erkhembayar Department of Paediatrics, University of Lagos, Lagos, Nigeria Christopher Imokhuede Esezobor Department of Paediatrics, Lagos University Teaching Hospital, Lagos, Nigeria Christopher Imokhuede Esezobor Preventive Medicine and Public Health Research Center, Iran University of Medical Sciences, Tehran, Iran Babak Eshrati & Maziar Moradi-Lakeh Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran Sharareh Eskandarieh & Mohammad Ali Sahraian Department of Obesity, Diabetes and Cardiovascular risk, National Institute of Public Health, Cuernavaca, Mexico Juan Espinosa-Montero Dipartimento di Scienze Biomediche e Neuromotorie, University of Bologna, Bologna, Italy Francesco Esposito Department of Internal Medicine, Yale University, New Haven, CT, USA Farshid Etaee Department of Pediatrics and Child Health Nursing, Wollega University, Nekemte, Ethiopia Werku Etafa Department of Virology, Pasteur Institute of Morocco, Casablanca, Morocco Sayeh Ezzikouri Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK Adeniyi Francis Fagbamigbe & Santosh Gaihre Interdisciplinary Neuroscience Research Program, Tehran University of Medical Sciences, Tehran, Iran Shahriar Faghani Epidemiology and Biostatistics Unit, National Cancer Institute IRCCS Fondazione G
[DOI] [PMC free article] [PubMed] [Google Scholar] 43.Garnacho-Castao M.V., Snchez-Nuo S., Molina-Raya L., Carbonell T., Mat-Muoz J.L., Pleguezuelos-Cobo E., Serra-Pay N
